Effects of CSL324 in the Lung After Segmental Challenge

NCT05653713 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: CSL324
DRUG: Placebo

Sponsor

CSL Behring